SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 342.97 |
| Enterprise Value ($M) | 396.97 |
| Book Value ($M) | 18.57 |
| Book Value / Share | 1.04 |
| Price / Book | 18.47 |
| NCAV ($M) | -10.84 |
| NCAV / Share | -0.61 |
| Price / NCAV | -31.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.31 |
| Return on Assets (ROA) | 0.29 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.95 |
| Current Ratio | 2.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 146.56 |
| Assets | 175.97 |
| Liabilities | 157.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 179.28 |
| Operating Income | 24.19 |
| Net Income | 17.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 31.47 |
| Cash from Investing | 4.13 |
| Cash from Financing | -11.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 8.48 | 31.60 | |
| 13G/A | BlackRock, Inc. | 7.70 | -20.94 | |
| 13G/A | Soleus Capital Master Fund, L.P. | 6.40 | 20.96 | |
| 13G/A | Invesco Ltd. | 0.00 | -99.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 55,121 | 150,519 | 36.62 | |
| 31,742 | 109,985 | 28.86 | |
| 32,404 | 119,620 | 27.09 | |
| 38,795 | 150,370 | 25.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| REPL – Replimune Group, Inc. | RGEN – Repligen Corporation |
| RGNX – REGENXBIO Inc. | RLMD – Relmada Therapeutics, Inc. |
| RLYB – Rallybio Corporation |